🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to assess the safety and immunogenicity of GlaxoSmit...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01196988
Treatments Being Tested
The purpose of the present study is to assess the immunogenicity and safety...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-10-08
Trial ID
NCT00985790
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, immunogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-10-01
Trial ID
NCT01439360
This study is designed to assess the safety and immunogenicity of a GSK Bio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01204671
Treatments Being Tested
The purpose of this trial is to demonstrate the acceptable safety profile a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08-18
Trial ID
NCT02207413
The purpose of this study is to assess, in adults 18 years of age and above...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-07-11
Trial ID
NCT01878812
Treatments Being Tested
The purpose of this observer-blind study is to evaluate the safety and immu...
Status
Terminated
Location
GSK Investigational Site
Start Date
2010-09-30
Trial ID
NCT01195779
The purpose of this study is to assess the safety and immunogenicity of GSK...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10-06
Trial ID
NCT01702454
Treatments Being Tested
The purpose of this study is to investigate the immunogenicity and safety w...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-01
Trial ID
NCT02218697
Treatments Being Tested
The purpose of this study is to assess immunogenicity, reactogenicity and s...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-03
Trial ID
NCT01954251